Polly Ann Niravath
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Family Practice top 5%
Papers in
-
- Advanced Breast Cancer Therapies 9
- Brain Metastases and Treatment 5
- Oncology 12
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 2
- Cancer Risks and Factors 2
- Co-authors
- Anhquyen Le (2 shared papers)Shigekazu Nagata (2 shared papers)Perumal Thiagarajan (2 shared papers)Rolando E. Rumbaut (2 shared papers)Hanan Abdel‐Monem (2 shared papers)Swapan Kumar Dasgupta (2 shared papers)Mothaffar F. Rimawi (7 shared papers)Susan Galloway Hilsenbeck (7 shared papers)
- Journals
- Advances in Therapy (6 papers)Breast Cancer Research and Treatment (5 papers)Clinical Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)Clinical Breast Cancer (2 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Polly Ann Niravath
47 papers receiving 1.7k citations
Polly Ann Niravath's Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 692
- Family Practice 39
- Cancer Research 274
- Urology 103
- Pulmonary and Respiratory Medicine 523
Countries citing papers authored by Polly Ann Niravath
This map shows the geographic impact of Polly Ann Niravath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Polly Ann Niravath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Polly Ann Niravath more than expected).
Fields of papers citing papers by Polly Ann Niravath
This network shows the impact of papers produced by Polly Ann Niravath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Polly Ann Niravath. The network helps show where Polly Ann Niravath may publish in the future.
Co-authors
The 25 scholars most cited alongside Polly Ann Niravath, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases Hit paper breakdown → | 2019 | 287 |
| 2 | 2008 | 170 | |
| 3 | 2013 | 169 | |
| 4 | 2017 | 165 | |
| 5 | 2017 | 161 | |
| 6 | 2016 | 142 | |
| 7 | 2021 | 84 | |
| 8 | 2018 | 53 | |
| 9 | 2019 | 47 | |
| 10 | 2020 | 44 | |
| 11 | 2019 | 33 | |
| 12 | 2022 | 31 | |
| 13 | 2021 | 29 | |
| 14 | 2018 | 28 | |
| 15 | 2015 | 23 | |
| 16 | 2016 | 23 | |
| 17 | 2017 | 18 | |
| 18 | 2019 | 15 | |
| 19 | 2021 | 15 | |
| 20 | 2016 | 14 |
About Polly Ann Niravath
Polly Ann Niravath is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics and Immunology, having authored 49 papers that have together received 1.7k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (9 papers), Estrogen and related hormone effects (5 papers), Brain Metastases and Treatment (5 papers), Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Risks and Factors (2 papers) and Menopause: Health Impacts and Treatments (2 papers). The work is most often cited by research in Oncology (692 citations), Family Practice (39 citations), Cancer Research (274 citations), Urology (103 citations) and Pulmonary and Respiratory Medicine (523 citations). Polly Ann Niravath has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Anhquyen Le, Shigekazu Nagata, Perumal Thiagarajan, Rolando E. Rumbaut, Hanan Abdel‐Monem, Swapan Kumar Dasgupta, Mothaffar F. Rimawi, Susan Galloway Hilsenbeck, Tao Wang and Meghana V. Trivedi. Their work appears in journals such as Advances in Therapy, Breast Cancer Research and Treatment, Clinical Cancer Research, Journal of Clinical Oncology and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.